Yong Man Kim
Keine laufenden Positionen mehr
Vermögen: 56 200 $ am 30.04.2024
Profil
Dr. Yong Man Kim is a Chief Scientific Officer & Director at NKMAX Co., Ltd.
and a Director & Chief Scientific Officer at NKGen Biotech, Inc. He is on the Board of Directors at NKMAX Co., Ltd.
and NKGen Biotech, Inc. Dr. Kim was previously employed as a Chief Scientific & Innovation Officer by NKGen Biotech, Inc. /US/ and a Research Professor by Wonkwang University.
He received his doctorate degree from Chungnam National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,12% | 29.04.2024 | 28 384 ( 0,12% ) | 56 200 $ | 30.04.2024 |
Aktive Positionen von Yong Man Kim
| Unternehmen | Position | Beginn |
|---|---|---|
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 |
Ehemalige bekannte Positionen von Yong Man Kim
| Unternehmen | Position | Ende |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
| Wonkwang University | Corporate Officer/Principal | - |
Ausbildung von Yong Man Kim
| Chungnam National University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |